Enterisol® Salmonella T/C is a safe, effective, convenient, one dose Salmonella Choleraesuis-Typhimurium vaccine.

  • The first dual antigen swine Salmonella vaccine
  • Early vaccination age – 2 weeks of age
  • Convenient oral delivery
  • Easy on pigs and people
  • PQA friendly – no needles
  • Another innovative oral vaccine from Boehringer Ingelheim Vetmedica, Inc.

Enterisol® Salmonella T/C Family:

  • Enterisol® Salmonella T/C FF 100 doses
  • Enterisol® Salmonella T/C FF 250 doses
  • Enterisol® Salmonella T/C FF 500 doses
  • Enterisol® Salmonella T/C 100 doses

Salmonella in the Pig Industry – Video Series

Learn more about the symptoms and epidemiology of Salmonella choleraesuis and typhimurium.

Product Resources

Contact Information

  • Boehringer Ingelheim Vetmedica, Inc.

    Swine Division

    3902 Gene Field Road
    St. Joseph, Missouri 64506

    • Phone 866-638-2226
    • Fax 816-676-4754
    • e-mail
  • First and only vaccine labeled to help prevent Salmonella is due to S. Typhimurium
  • Conveniently vaccinate for S. Typhimurium and S. Choleraesuis in a single oral dose
  • The first and only dual antigen swine Salmonella vaccine for dual protection against Choleraesuis and Typhimurium

Enterisol® Salmonella Advantages

  • The first swine vaccine to contain both Salmonella Choleraesuis and Salmonella Typhimurium antigens in one dose.
  • The first swine Salmonella vaccine to have the “Aids in prevention” claim for both S. Choleraesuis and S. Typhimurium.
  • Can be used in young pigs — it is approved for use in pigs as young as 2 weeks of age.
  • The vaccine provides rapid onset of immunity after administration.1
  • Enterisol® Salmonella T/C combines the advantages of Enterisol® SC-54 with a Salmonella Typhimurium antigen for even better protection.
  • Oral delivery of the vaccine results in less stress for pigs, plus improved pork quality as well as improved worker safety and convenience by eliminating the need for injections.
  • Enterisol® Salmonella T/C is available in two formulations: lyophilized (freeze-dried) or frozen.

Extensive field and research studies show the effectiveness and safety of Enterisol® Salmonella T/C in reducing the effects of disease in pigs exposed to S. Choleraesuis and S. Typhimurium. The two charts below show the results of the efficacy studies:

  • Common type of Salmonella on swine operations
  • Causes clinical diarrhea, often lasting three to seven days
  • Can lead to dehydration and reduced performance
  • Poses food safety risk to humans, so producers should be vigilant in prevention


1 Boehringer Ingelheim Vetmedica, Inc. Study No. 2013210
2 Boehringer Ingelheim Vetmedica, Inc. Study No. 2011168
3 Boehringer Ingelheim Vetmedica, Inc. Study No. 2012104